XPRO Crashes 24% in a Week as Earnings Disappoint and Shorts Stay Put
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
XPRO dropped 15.9% on November 3 alone, capping a brutal week that saw the stock shed nearly a quarter of its value to close at $13.34, and the most telling detail is that short sellers barely moved.
The post-earnings collapse is the dominant story this week. Expro reported on November 3, and the market's reaction was swift and severe. The next scheduled print is not until February 18, 2027, leaving 106 days for the dust to settle. For context, the most recent prior earnings event in October 2026 generated a much calmer 1-day move of just under 1%. The severity of this week's reaction is therefore a material departure from recent form.
Positioning tells a complicated story, given that this sell-off did not come with meaningful short-seller activity. Short interest edged down 1.1% on the day of the drop and is up only 1.5% on the week, leaving roughly 7.05 million shares short. That is actually lower than levels seen in mid-October, when short interest briefly climbed above 8.3 million shares before retreating. The borrow market reflects this calm: cost to borrow has drifted down to 0.42%, a 30-day low and well below the 0.80% spike seen on October 14. Availability is loose at 761%, meaning there are roughly seven and a half shares available to borrow for every one currently lent out. Shorts are not piling in on the collapse, nor are they being squeezed out. The ORTEX short score of 53.2 is similarly unremarkable, drifting down from 57 three weeks ago. The options market has swung dramatically, however. The put/call ratio has risen to 0.84, nearly double its 20-day average of 0.49, and the highest sustained level in at least a year. That is not far from the 52-week peak of 1.25, suggesting investors bought downside protection heavily ahead of the print, or are continuing to hold it in its aftermath.
The Street's response sharpens the concern. Piper Sandler's analyst cut the price target to $15 from $16 on November 4, maintaining an Underweight rating. That action is particularly notable because it arrived after the stock had already fallen to $13.34, meaning even the bearish camp's target is now above the current price. The consensus mean target across the broader analyst group stands at $17.25, implying roughly 29% upside at current levels. Barclays remains Overweight but last updated its target in late July at $19, before the recent deterioration. The forward earnings yield factor scores just 46 out of 100, and the EV/EBITDA multiple has compressed sharply, down nearly 0.79 turns on the day of the drop to 4.0x. The EPS surprise score ranks in only the 8th percentile, a signal that beating estimates has not been a consistent feature of recent quarters. One outlier worth flagging: the 12-month forward EPS year-on-year increase factor scores in the 99th percentile, suggesting analysts still expect meaningful profit growth, even after whatever drove this week's sell-off.
The ownership picture adds another layer. Oak Hill Advisors filed a Schedule 13D in April 2026, meaning there is a confirmed activist on the register holding around 10.5% of shares outstanding. Schedule 13D/G positions are event-driven disclosures around the 5% threshold; stakes are as last disclosed, and holders dropping below 5% can exit without further filing. T. Rowe Price is the largest institutional holder at approximately 17.6% of shares, and American Century added over 3.5 million shares in the quarter ending September 30. Against this, FMR (Fidelity) filed to show a zero position in August after previously holding 5.9%, and Dimensional exited in October. The $100 million buyback authorization announced November 3 alongside the earnings release is a notable backstop signal from management, though as noted in the prior ORTEX note, no shares have necessarily been repurchased yet.
Wikipedia attention for XPRO is running at a z-score of 4.5 against its own 90-day history, as of October 22, the highest retail attention reading in the data. With the stock now trading at $13.34, well below any analyst target on the board, and an activist on the register, the key question heading into February's earnings is whether the buyback program translates into actual repurchase activity and whether management's forward guidance can close the gap between the 99th-percentile EPS growth expectation and an 8th-percentile track record on surprises.
Stocks in this article
See the live data behind this article on ORTEX.
Open XPRO on ORTEX →How this article was generated
- Generated
- 4 Nov 2026, 21:27
- Data as of
- 4 Nov 2026, 21:18
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.